Viatris Inc. (VTRS) stock analysis
In our weekly check, Viatris Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 13 pass, warnings: 3, red flags: 7.
About Viatris Inc.
Viatris Inc. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in the United States, listed on NASDAQ as VTRS.
What our checks show for VTRS
Red flags
- The company has an operating loss, so it does not cover the interest bill: interest is paid from cash or new debt.
- Revenue fell 3.3% a year over the last 3 years.
- Earnings per share fell 32.3% a year over the last 3 years.
- The company is losing money: the net margin is -4.1%.
- Viatris Inc. pays a dividend while losing money: it is funded from reserves or debt.
- The stock has fallen as much as 90% from a peak. Would you have held through that?
- Return on capital (ROCE) is zero or negative: the business does not earn on the money put into it.
Warning signs
- Net debt is 4.1x a year of EBITDA (debt/equity 0.99). That limits room in a downturn and raises refinancing risk.
- Analysts expect only about 3.4% a year of growth in revenue.
- The stock is still below its previous peak.
Strengths
- The net margin rose by 3 points over 5 years, to -4.1%.
- The gross margin is 35.2% and has risen by 4 points: pricing power is holding.
- Operating cash flow is 4.09x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 115% a year over the next years.
- Analysts expect the net margin to improve by 25.2 points from today's -4.1%.
- Free cash flow is 13.9% of revenue: cash for dividends, buybacks or growth.
Similar companies
ZTS · HLN · ELAN · TEVA · TAK · ALKS
Questions
What grade does Viatris Inc. (VTRS) have?
In our weekly check, Viatris Inc. is graded C (A to F). Of 23 checks on debt, profit, cash flow and trend: 13 pass, warnings: 3, red flags: 7. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of VTRS stock?
This week's biggest flags for Viatris Inc.: Weak interest cover, Weak revenue growth, Weak EPS growth. In total 10 of 23 checks show a warning or a red flag.
What does Viatris Inc. do?
Viatris Inc. is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in the United States, listed on NASDAQ as VTRS.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis